2m 2m 2m 2m 2m 2m 2m
Cnbs Strgc Vnts (NUGS)
OTC
$0.010-$0.003 (-24.43%)
Price as of Sep 11, 2026- N/AMarket Cap
- 989,900.00%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Cnbs Strgc Vnts (NUGS)
$0.010-$0.003 (-24.43%)
NUGS | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.01 | ||
Change | -$0.003 (-24.43%) | ||
Open | $0.01 | ||
High | $0.01 | ||
Low | $0.01 | ||
Previous Close | $0.01 | ||
Volume | 9,245,507 | ||
30-Day Average Volume | 4,147,666 | ||
1-Week Change | -17.50% | ||
1-Month Change | 2,375.00% | ||
1-Year Change | 989,900.00% | ||
3-Year Change | 989,900.00% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 159.3M | ||
Total Assets | $1,250.00 | ||
Market Cap | N/A | ||
Enterprise Value | N/A | ||
Period: QTR TTM FY | |||
Revenue | -$3,203.00 | ||
Net Income | -$9,963.00 | ||
Free Cash Flow | N/A | ||
EBIT | -$9,963.00 | ||
EBITDA | -$9,963.00 | ||
Net Working Capital | N/A | ||
EPS | N/A | ||
Enterprise Value/EBITDA | N/A | ||
Enterprise Value/Revenue | N/A | ||
P/B | -323 | ||
P/E | N/A | ||
PEG | N/A | ||
Price/Free Cash Flow | N/A | ||
Price/Operating Cash Flow | N/A | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 8 : 1 | ||
Last Split Date | 05/06/2005 | ||